General Information of the Compound
Compound ID
CP0353892
Compound Name
JNJ-18038683
    Show/Hide
Synonyms
5-HT 7 antagonist (depression), Johnson & Johnson
JNJ-18038683
Serotonin 7 antagonist (depression), Johnson & Johnson
    Show/Hide
Structure
Formula
C20H20ClN3
Molecular Weight
337.854
Canonical SMILES
Clc1ccc(cc1)-c1nn(Cc2ccccc2)c2CCNCCc12
    Show/Hide
InChI
InChI=1S/C20H20ClN3/c21-17-8-6-16(7-9-17)20-18-10-12-22-13-11-19(18)24(23-20)14-15-4-2-1-3-5-15/h1-9,22H,10-14H2
    Show/Hide
InChIKey
UKJPMZGILXATGT-UHFFFAOYSA-N
CAS
851373-91-6
Physicochemical Property
logP
3.94
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
29.85
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11151899
SID: 16230662
ChEMBL ID
CHEMBL4205783
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01746, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 6 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( JNJ-18038683 )
Drug Name JNJ-18038683
Company Johnson & Johnson
Indication
Major depressive disorder
Phase 2
Target(s)
5-HT 7 receptor (HTR7)
Antagonist